Role of syndecan-1 (CD138) in cell survival of human urothelial carcinoma.
about
Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesionROS generation via NOX4 and its utility in the cytological diagnosis of urothelial carcinoma of the urinary bladderClinical implications in the shift of syndecan-1 expression from the cell membrane to the cytoplasm in bladder cancerLeaf Extracts of Calocedrus formosana (Florin) Induce G2/M Cell Cycle Arrest and Apoptosis in Human Bladder Cancer CellsmicroRNA-145 promotes differentiation in human urothelial carcinoma through down-regulation of syndecan-1.MiR-302a inhibits the tumorigenicity of ovarian cancer cells by suppression of SDC1HER2 Protein Overexpression and Gene Amplification in Plasmacytoid Urothelial Carcinoma of the Urinary Bladder.Plasmacytoid urothelial carcinoma--diagnostic challenge in cytology.Targeted therapies in bladder cancer: an overview of in vivo research.Syndecan-1 up-regulates microRNA-331-3p and mediates epithelial-to-mesenchymal transition in prostate cancer.Syndecan-1 (CD138) contributes to prostate cancer progression by stabilizing tumour-initiating cells.Syndecan-1 expression in human glioma is correlated with advanced tumor progression and poor prognosis.Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?Molecular targets and signaling pathways regulated by nuclear translocation of syndecan-1.Insulin suppresses MPP+-induced neurotoxicity by targeting integrins and syndecans in C6 astrocytes.Urinary bladder urothelial carcinoma with concurrent plasmacytoid and micropapillary differentiations: A report of two cases with an emphasis on serum carbohydrate antigen 19-9.Syndecan-1 regulates adipogenesis: new insights in dedifferentiated liposarcoma tumorigenesis.Prognostic significance of syndecan-1 expression in squamous cell carcinoma of the tonsil.The plasmacytoid carcinoma of the bladder--rare variant of aggressive urothelial carcinoma.
P2860
Q28282509-1ADAC008-80FA-44A3-B6A3-8EDC482859C7Q34059983-EEF47FBF-3684-4473-B69E-E0CC92E5EB1EQ35093807-C1878E30-2463-4870-8888-60ECA16469D7Q35094225-EB6B3A0A-4DD1-462A-A62F-A814B268433FQ35826468-B852FEFF-5DBB-4EA6-8454-782E5E7D8978Q35853982-5E54AEAB-9BF7-41B9-A8EE-4C6E30B53B0EQ36724623-12FD63F4-A4A8-408A-9CA7-C5F8ACD6B339Q38006912-6924F2A1-E3EB-40A6-9B9C-17F941AAD498Q38590471-D1B64FE1-5402-4947-AE7D-921FFCA10B7FQ38844891-E0B92F08-5E31-436C-9AC0-F9A2B0CFC644Q39022839-1570E306-1DB6-425F-B54F-C0593490FD58Q46059085-0108C4CE-F45D-43A9-885D-E1E72834FA90Q47281580-2D523619-7D08-4A92-84C3-4F9C4B04609FQ47318797-885C8F48-121D-47AB-A7C2-411008D28E82Q47884764-8263DA6D-DAD9-4DE8-A55C-C144D0E39811Q48179048-06D27165-18DA-4C00-8DAF-7A69FCC3EF47Q51040058-518C3FCA-1D44-4BBF-BD16-50A362209A18Q53334967-9F72CF87-7965-4CA3-9002-33EB131B63DAQ54647137-4F313095-157A-4B4F-96AD-E6829CF5583E
P2860
Role of syndecan-1 (CD138) in cell survival of human urothelial carcinoma.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Role of syndecan-1 (CD138) in cell survival of human urothelial carcinoma.
@en
Role of syndecan-1
@nl
type
label
Role of syndecan-1 (CD138) in cell survival of human urothelial carcinoma.
@en
Role of syndecan-1
@nl
prefLabel
Role of syndecan-1 (CD138) in cell survival of human urothelial carcinoma.
@en
Role of syndecan-1
@nl
P2093
P1433
P1476
Role of syndecan-1 (CD138) in cell survival of human urothelial carcinoma
@en
P2093
Kazuya Hirao
Keiji Shimada
Kiyohide Fujimoto
Makito Miyake
Mitsutoshi Nakamura
Motoyoshi Tanaka
Noboru Konishi
Yukiteru Ouji
P2860
P304
P356
10.1111/J.1349-7006.2009.01379.X
P577
2009-10-06T00:00:00Z